Clonal haematopoiesis to clonal cytopenias: unravelling disease evolution over time
- 17 July 2025
- journal article
- review article
- Published by Elsevier in The Lancet Haematology
- Vol. 12 (8) , e650-e661
Abstract
No abstract availableKeywords
Funding Information
- Blood Cancer UK (23001)
- European Hematology Association (BCG-202209-02649)
- Robert and Arlene Kogod Center on Aging
- National Institutes of Health National Cancer Institute (R01 CA 272496-02)
This publication has 74 references indexed in Scilit:
- Clonal hematopoiesis of indeterminate potential is associated with reduced risk of cognitive impairment in patients with chronic kidney diseaseAlzheimer's & Dementia, 2024
- Features and Factors Associated With Myeloid Neoplasms After Chimeric Antigen Receptor T-Cell TherapyJAMA Oncology, 2024
- Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variantsAmerican Journal of Hematology, 2023
- T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancersCancer Cell, 2023
- Clinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective mayo clinic cohort studyLeukemia Research, 2022
- The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high‐risk clonal cytopenia of unknown significanceGenes, Chromosomes and Cancer, 2022
- Clonal Hematopoiesis and Myeloid Neoplasms in the Context of Telomere Biology DisordersCurrent Hematologic Malignancy Reports, 2022
- PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic ChemotherapyCell Stem Cell, 2018
- Critical Role of Jak2 in the Maintenance and Function of Adult Hematopoietic Stem CellsStem Cells, 2014
- Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conferenceLeukemia Research, 2007